Ellison says the settlement requires Novo Nordisk to provide insulin products—including Novolog, Tresiba, Fiasp, and Novolin, at any formulation and via any delivery method—at $35 per monthly ...
Novo Nordisk said it will cut the list prices in ... Fiasp's price will be reduced by 75%, making it the same price as NovoLog (insuin aspart), while Tresiba's price will be reduced by 72% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback